BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He Z, Li G, Tang L, Li Y. SIX1 overexpression predicts poor prognosis and induces radioresistance through AKT signaling in esophageal squamous cell carcinoma. Onco Targets Ther 2017;10:1071-9. [PMID: 28260921 DOI: 10.2147/OTT.S125330] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu Y, Tang Y, Li P. Inhibitory effect of microRNA-455-5p on biological functions of esophageal squamous cell carcinoma Eca109 cells via Rab31. Exp Ther Med 2018;16:4959-66. [PMID: 30542452 DOI: 10.3892/etm.2018.6820] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
2 Luo Q, Du R, Liu W, Huang G, Dong Z, Li X. PI3K/Akt/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted Therapy. Front Oncol 2022;12:852383. [PMID: 35392233 DOI: 10.3389/fonc.2022.852383] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wang H, Xue W, Ouyang W, Jiang X, Jiang X. miR-23a-3p/SIX1 regulates glucose uptake and proliferation through GLUT3 in head and neck squamous cell carcinomas. J Cancer 2020;11:2529-39. [PMID: 32201523 DOI: 10.7150/jca.30995] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li HL, Sun JJ, Ma H, Liu SJ, Li N, Guo SJ, Shi Y, Xu YY, Qi ZY, Wang YQ, Wang F, Guo RM, Liu D, Xue FX. MicroRNA-23a inhibits endometrial cancer cell development by targeting SIX1. Oncol Lett 2019;18:3792-802. [PMID: 31579409 DOI: 10.3892/ol.2019.10694] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
5 Chen G, Chen Z, Zhao H. MicroRNA-155-3p promotes glioma progression and temozolomide resistance by targeting Six1. J Cell Mol Med 2020;24:5363-74. [PMID: 32220051 DOI: 10.1111/jcmm.15192] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
6 Nie ZY, Liu XJ, Zhan Y, Liu MH, Zhang XY, Li ZY, Lu YQ, Luo JM, Yang L. miR-140-5p induces cell apoptosis and decreases Warburg effect in chronic myeloid leukemia by targeting SIX1. Biosci Rep 2019;39:BSR20190150. [PMID: 30962263 DOI: 10.1042/BSR20190150] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
7 Ge P, Cao L, Yao YJ, Jing RJ, Wang W, Li HJ. lncRNA FOXD2-AS1 confers cisplatin resistance of non-small-cell lung cancer via regulation of miR185-5p-SIX1 axis. Onco Targets Ther 2019;12:6105-17. [PMID: 31534348 DOI: 10.2147/OTT.S197454] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
8 Yang Z, Feng Z, Gu J, Li X, Dong Q, Liu K, Li Y, OuYang L. microRNA-488 inhibits chemoresistance of ovarian cancer cells by targeting Six1 and mitochondrial function. Oncotarget 2017;8:80981-93. [PMID: 29113360 DOI: 10.18632/oncotarget.20941] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
9 Wan J, Yang J, Qiao C, Sun X, Di A, Zhang L, Wang D, Zhao G. MicroRNA-362 Inhibits Cell Proliferation and Invasion by Directly Targeting SIX1 in Colorectal Cancer. Yonsei Med J 2019;60:414-22. [PMID: 31016902 DOI: 10.3349/ymj.2019.60.5.414] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Zhu G, Liu Y, Zhao L, Lin Z, Piao Y. The Significance of SIX1 as a Prognostic Biomarker for Survival Outcome in Various Cancer Patients: A Systematic Review and Meta-Analysis. Front Oncol 2021;11:622331. [PMID: 34745930 DOI: 10.3389/fonc.2021.622331] [Reference Citation Analysis]
11 Wang L, Wang M, Zhang M, Li X, Zhu Z, Wang H. Expression and significance of RRBP1 in esophageal carcinoma. Cancer Manag Res 2018;10:1243-9. [PMID: 29844703 DOI: 10.2147/CMAR.S158013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
12 Zhan H, Chen H, Tang Z, Liu S, Xie K, Wang H. SIX1 attenuates inflammation and rheumatoid arthritis by silencing MyD88-dependent TLR1/2 signaling. Int Immunopharmacol 2022;106:108613. [PMID: 35180623 DOI: 10.1016/j.intimp.2022.108613] [Reference Citation Analysis]
13 Qiu L, Hu Y, Deng ZM. Significance of expression of SIX1 and CD147 in gastric adenocarcinoma. Shijie Huaren Xiaohua Zazhi 2018; 26(30): 1742-1747 [DOI: 10.11569/wcjd.v26.i30.1742] [Reference Citation Analysis]